In vivo challenging of polymyxins and levofloxacin eye drop against multidrug-resistant Pseudomonas aeruginosa keratitis.

[1]  K. Y. Seo,et al.  Comparative Intraocular Penetration of 4 Fluoroquinolones After Topical Instillation , 2013, Cornea.

[2]  S. Leal,et al.  Host Response and Bacterial Virulence Factor Expression in Pseudomonas aeruginosa and Streptococcus pneumoniae Corneal Ulcers , 2013, PloS one.

[3]  Kazuki Tajima,et al.  Methicillin-resistant Staphylococcus aureus keratitis in a dog. , 2013, Veterinary ophthalmology.

[4]  Yoshiaki Yamagishi,et al.  Nosocomial outbreak of multidrug-resistant Pseudomonas aeruginosa caused by damaged transesophageal echocardiogram probe used in cardiovascular surgical operations , 2013, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.

[5]  Hironori Tanaka,et al.  Evaluation in vitro of the efficacy of colistin methanesulfonate against biofilm-forming multidrug-resistant Pseudomonas aeruginosa (MDRP) , 2013, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.

[6]  E. Cohen,et al.  Trends in Contact Lens–Related Corneal Ulcers at a Tertiary Referral Center , 2012, Cornea.

[7]  D. Park,et al.  Rate of Isolation and Trends of Antimicrobial Resistance of Multidrug Resistant Pseudomonas Aeruginosa from Otorrhea in Chronic Suppurative Otitis Media , 2012, Clinical and experimental otorhinolaryngology.

[8]  S. Thanos,et al.  Microbiological findings and predisposing risk factors in corneal ulcers , 2012, Graefe's Archive for Clinical and Experimental Ophthalmology.

[9]  W. Chun,et al.  Use of parenteral colistin for the treatment of multiresistant Gram-negative organisms in major burn patients in South Korea , 2012, Infection.

[10]  P. Jorens,et al.  A retrospective observational study on the efficacy of colistin by inhalation as compared to parenteral administration for the treatment of nosocomial pneumonia associated with multidrug-resistant Pseudomonas aeruginosa , 2011, BMC infectious diseases.

[11]  M. Falagas,et al.  Colistin: recent data on pharmacodynamics properties and clinical efficacy in critically ill patients , 2011, Annals of intensive care.

[12]  A. Matsubara,et al.  Sporadic isolations of a multi-drug resistant Pseudomonas aeruginosa clone during a 14-month epidemic in a general hospital in Hiroshima , 2011, Infection.

[13]  W. Petroll,et al.  Castroviejo Lecture 2009: 40 Years in Search of the Perfect Contact Lens , 2010, Cornea.

[14]  E. Stangogiannis-Druya,et al.  Úlcera corneal bacteriana tratada con antibiótico intraestromal: Modelo experimental in vivo , 2009 .

[15]  R. Naranjo-Tackman,et al.  [Bacterial corneal ulcer treated with intrastromal antibiotic. Experimental model in vivo]. , 2009, Archivos de la Sociedad Espanola de Oftalmologia.

[16]  K. Tateda,et al.  Efficacy of colistin combination therapy in a mouse model of pneumonia caused by multidrug-resistant Pseudomonas aeruginosa. , 2009, The Journal of antimicrobial chemotherapy.

[17]  Jian Li,et al.  Polymyxin B for the treatment of multidrug-resistant pathogens: a critical review. , 2007, The Journal of antimicrobial chemotherapy.

[18]  A. Gales,et al.  Intravenous polymyxin B for the treatment of nosocomial pneumonia caused by multidrug-resistant Pseudomonas aeruginosa. , 2007, International journal of antimicrobial agents.

[19]  J. Turnidge,et al.  Colistin: the re-emerging antibiotic for multidrug-resistant Gram-negative bacterial infections. , 2006, The Lancet. Infectious diseases.

[20]  F. Stapleton,et al.  Type III Secretion System–Associated Toxins, Proteases, Serotypes, and Antibiotic Resistance of Pseudomonas aeruginosa Isolates Associated with Keratitis , 2006, Current eye research.

[21]  Matthew E Falagas,et al.  Colistin: the revival of polymyxins for the management of multidrug-resistant gram-negative bacterial infections. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[22]  J. Turnidge,et al.  Evaluation of colistin as an agent against multi-resistant Gram-negative bacteria. , 2005, International journal of antimicrobial agents.

[23]  I. Hemo,et al.  Efficacy of topical gentamicin treatment after 193-nm photorefractive keratectomy in an experimental Pseudomonas keratitis model , 1995, Graefe's Archive for Clinical and Experimental Ophthalmology.

[24]  G. Turett,et al.  Polymyxin B Nephrotoxicity and Efficacy against Nosocomial Infections Caused by Multiresistant Gram-Negative Bacteria , 2003, Antimicrobial Agents and Chemotherapy.

[25]  G. Bukholm,et al.  An Outbreak of Multidrug-Resistant Pseudomonas Aeruginosa Associated with Increased Risk of Patient Death in an Intensive Care Unit , 2002, Infection Control & Hospital Epidemiology.

[26]  D. Livermore,et al.  Multiple mechanisms of antimicrobial resistance in Pseudomonas aeruginosa: our worst nightmare? , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[27]  M. Kilian,et al.  Epidemic Population Structure of Pseudomonas aeruginosa: Evidence for a Clone That Is Pathogenic to the Eye and That Has a Distinct Combination of Virulence Factors , 2001, Infection and Immunity.

[28]  M. Douglas,et al.  Multi-drug resistant Pseudomonas aeruginosa outbreak in a burns unit--an infection control study. , 2001, Burns : journal of the International Society for Burn Injuries.

[29]  Mary Jane Ferraro,et al.  Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically : approved standard , 2000 .

[30]  Aize Kijlstra,et al.  Incidence of contact-lens-associated microbial keratitis and its related morbidity , 1999, The Lancet.

[31]  S. Fleiszig,et al.  Pseudomonas aeruginosa-mediated cytotoxicity and invasion correlate with distinct genotypes at the loci encoding exoenzyme S , 1997, Infection and immunity.

[32]  J. A. Hobden,et al.  Topical antibiotic therapy for the treatment of experimental Staphylococcus aureus keratitis. , 1992, Investigative ophthalmology & visual science.

[33]  J. A. Hobden,et al.  The role of pneumolysin in ocular infections with Streptococcus pneumoniae. , 1990, Current eye research.

[34]  R. Gray,et al.  Inhibition of Pseudomonas aeruginosa elastase and Pseudomonas keratitis using a thiol-based peptide , 1990, Antimicrobial Agents and Chemotherapy.

[35]  S. Mitsuhashi,et al.  In Vitro Antibacterial Activity of AM-715, a New Nalidixic Acid Analog , 1980, Antimicrobial Agents and Chemotherapy.

[36]  J. Homma,et al.  Pathogenesis of the mouse keratitis produced with Pseudomonas aeruginosa. , 1975, The Japanese journal of experimental medicine.

[37]  T. Mizukawa,et al.  [TOPICAL USE OF COLIMYCIN-S IN OPHTHALMOLOGY]. , 1964, Nihon ganka kiyo.

[38]  I. Leopold,et al.  Intraocular penetration of colistin. , 1962, Archives of ophthalmology.